The progress continues....
http://www.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20071213005158&newsLang=en
... and SIRT management is sharing its findings in the most appropriate forums.
Subscribe to:
Post Comments (Atom)
4 comments:
It appears that this is not new news at all. I think it's just a rehash of the mice study. That would explain the lack of upside movement in the stock today.
You are correct in that it is not new news. However, it is about SIRT's NCE (New Chemical Entity) that is unrelated to resveratrol and 1,000 times more potent. At the time of the November 2006 mice study the focus was on SIRT501, a proprietary resveratrol coumpound. The next expected important piece of news will be the IIIb clinical results due out within a couple of weeks.
It all comes down to the first clinical trial numbers in humans. I agree this will be the rocket fuel if it works or this stock will explode on it's launch pad. I've got my stops in if this trial does not work. Do you take resveratrol yourself?
Yes I do take resveratrol. I've been taking it for about 8 months.
Post a Comment